BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT04387552 updates: 1. enrollment: 2126 → 2093 participants 2. intervention model: FACTORIAL → SEQUENTIAL
Clinical trial NCT04387552 updates: 1. enrollment: 2126 → 2093 participants 2. intervention model: FACTORIAL → SEQUENTIAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical